OtoNexus Medical Technologies has developed an innovative ultrasound otoscope designed to enhance the detection of middle ear infections, specifically otitis media. This device utilizes a proprietary ultrasound technology that allows for rapid and accurate identification of both viral and bacterial infections within seconds, significantly improving upon traditional visual inspection methods. The miniaturized ultrasound technology fits into the tip of an ear speculum, making it user-friendly and easily integrated into clinical workflows. By providing clear, objective data, the OtoNexus otoscope enables healthcare providers to make informed decisions regarding antibiotic prescriptions, thereby minimizing unnecessary use and reducing healthcare costs.

The OtoNexus ultrasound otoscope not only detects the presence of middle ear effusion but also differentiates between infection types, which is crucial for effective treatment. The device is designed for ease of use by various healthcare professionals and features automated measurements that ensure consistent results. Additionally, it offers seamless integration with electronic medical records (EMRs), streamlining documentation and enhancing clinical efficiency. Recognized for its groundbreaking technology, OtoNexus has been selected for the FDA's Safer Technologies Program (STeP), validating its potential to significantly improve patient care and safety in the diagnosis and management of middle ear infections.

United States

A device from OtoNexus Medical Technologies uses air-coupled ultrasound technology to accurately assess middle ear infections, and in particular to differentiate when and when not to prescribe antibiotics.

OtoNexus Medical Technologies

Company Details